Zion Research has published a new report titled “Active Pharmaceutical Ingredients Market by API Synthesis (Biotech API, Synthetic Chemical API, and HPAPI), by Type of Manufacturing (Contract Manufacturing and In-House API Manufacturing), by Type of API (Synthetic API and Biological API), by Drug Type (Branded Drugs, Generic Drugs and OTC Drugs), for Cardiology, Oncology, Anti-Inflammatory, Gastrointestinal and Other Application - Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 – 2021”. According to the report, global demand for active pharmaceutical ingredient market was valued at USD 148.22 billion in 2015, is expected to reach USD 213.84 billion in 2021 and is anticipated to grow at a CAGR of 6.3% between 2016 and 2021.
APIs are frequently referred as "bulk pharmaceuticals”. Active pharmaceutical ingredient is a biologically active portion of any pharmaceutical drug. Occasionally, API needs cofactor in order to attain specific effects on body. Some active pharmaceutical ingredients are unidentified and therefore need additional substances, which can work in combination with the API to generate the required medicinal effect on body. In herbal medicines, the API is generally a mixture of various substances, which act collectively on the body.
Request Report Sample https://www.zionmarketresearch.com/sample/active-pharmaceutical-ingredients-market
The market for API is expected to have the highest growth rate in the forecast period. Increasing prevalence of diabetes, neurological disorders and other chronic diseases are the major driving factor of the global API market. One of the key drivers of the API market is an increase in the outsourcing of active pharmaceutical ingredients manufactured by pharmaceutical companies which is done to reduce both manufacturing and infrastructure costs. Such outsourced manufacturing activities are carried out by low-cost vendors in the Asia Pacific region.
However, strict regulations are one of the major challenges faced by the global API market. Such regulations are predominantly well defined in developed regions such as North America and Europe. Vendors in this market space are supposed to obey the detailed procedures prior to product commercialization.
The global API market is segmented based on API synthesis, type of manufacturing, and type of API, application and by region. Depending on synthesis market is classified in to biotech API, synthetic chemical API, and HPAPI. On the basis of type of drug, the market is segmented into branded drugs, generic drugs and OTC (Over the Counter) drugs. The branded drug segment accounted for largest share in 2015. Different therapeutic application of the API market include cardiology, oncology, anti-inflammatory, gastrointestinal and others. The oncology segment is anticipated to grow at the highest growth rate in coming years due to increasing prevalence of cancer worldwide.
Browse the full "Active Pharmaceutical Ingredients Market by API Synthesis (Biotech API, Synthetic Chemical API, and HPAPI), by Type of Manufacturing (Contract Manufacturing and In-House API Manufacturing), by Type of API (Synthetic API and Biological API), by Drug type (Into Branded Drugs, Generic Drugs and OTC Drugs), for Cardiology, Oncology, Anti-Inflammatory, Gastrointestinal and Other Application - Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021" report at https://www.zionmarketresearch.com/report/active-pharmaceutical-ingredients-market
North America is leading market for API and acquired largest share in 2015. Asia Pacific region is expected to emerge as fastest growing region due to low operation costs and high investments in medical research. Furthermore the high cost of trained labor and energy are the most important factors that enforced European market to move their base to developing countries such as India and China.
Sun Pharmaceuticals Industries Limited, Novartis International AG, BASF SE, Pfizer, Inc., Aurobindo, Albemarle Corporation, and Boehringer Ingelheim among others are some of the leading players in API market.
The report segments the global active pharmaceutical ingredient market as
Active Pharmaceutical Ingredient Market: API Synthesis Segment Analysis
- Biotech API
- Synthetic Chemical API
- HPAPI
Active Pharmaceutical Ingredient Market: Type of Manufacturing Segment Analysis
- Contract Manufacturing
- In-House API Manufacturing
Active Pharmaceutical Ingredient Market: Type of API Segment Analysis
- Synthetic API
- Biological API
Active Pharmaceutical Ingredient Market: Drug Type Segment Analysis
- Branded Drugs
- Generic Drugs
- OTC Drugs
Active Pharmaceutical Ingredient Market: Therapeutic Application Segment Analysis
- Cardiology
- Oncology
- Anti-Inflammatory
- Gastrointestinal
- Other
Request for table of Contents https://www.zionmarketresearch.com/toc/active-pharmaceutical-ingredients-market
About Us
Zion Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Zion Market Research experienced team of Analysts, Researchers, and Consultants uses proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Contact US:
